Home LiteratureArticle Details
PMID: 12499208 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin.

Antimicrobial agents and chemotherapy ·Vol. 47 ·No. 1 ·2003-01-00 ·Pages 317-23

Walters MC, Roe F, Bugnicourt A, Franklin MJ, Stewart PS

Abstract

The roles of slow antibiotic penetration, oxygen limitation, and low metabolic activity in the tolerance of Pseudomonas aeruginosa in biofilms to killing by antibiotics were investigated in vitro. Tobramycin and ciprofloxacin penetrated biofilms but failed to effectively kill the bacteria. Bacteria in colony biofilms survived prolonged exposure to either 10 micro g of tobramycin ml(-1)or 1.0 micro g of ciprofloxacin ml(-1). After 100 h of antibiotic treatment, during which the colony biofilms were transferred to fresh antibiotic-containing plates every 24 h, the log reduction in viable cell numbers was only 0.49 +/- 0.18 for tobramycin and 1.42 +/- 0.03 for ciprofloxacin. Antibiotic permeation through colony biofilms, indicated by a diffusion cell bioassay, demonstrated that there was no acceleration in bacterial killing once the antibiotics penetrated the biofilms. These results suggested that limited antibiotic diffusion is not the primary protective mechanism for these biofilms. Transmission electron microscopic observations of antibiotic-affected cells showed lysed, vacuolated, and elongated cells exclusively near the air interface in antibiotic-treated biofilms, suggesting a role for oxygen limitation in protecting biofilm bacteria from antibiotics. To test this hypothesis, a microelectrode analysis was performed. The results demonstrated that oxygen penetrated 50 to 90 micro m into the biofilm from the air interface. This oxic zone correlated to the region of the biofilm where an inducible green fluorescent protein was expressed, indicating that this was the active zone of bacterial metabolic activity. These results show that oxygen limitation and low metabolic activity in the interior of the biofilm, not poor antibiotic penetration, are correlated with antibiotic tolerance of this P. aeruginosa biofilm system.

MeSH Terms
Biofilms/drug effects Ciprofloxacin/pharmacology Pseudomonas aeruginosa/drug effects,metabolism Tobramycin/pharmacology
Chemicals
Ciprofloxacin Tobramycin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Walters Marshall C
Center for Biofilm Engineering, Department of Chemical Engineering, Montana State University-Bozeman, Bozeman, Montana 59717-3980, USA.
Roe Frank
Bugnicourt Amandine
Franklin Michael J
Stewart Philip S
References (34)
34 references, click to expand
  1. Biofilm resistance to antimicrobial agents.
    Microbiology. 2000 Mar;146 ( Pt 3):547-9 PMID: 10746758
  2. Tolerance of Pseudomonas aeruginosa to killing by ciprofloxacin, gentamicin and imipenem in vitro and in vivo.
    J Antimicrob Chemother. 1988 Apr;21(4):395-404 PMID: 3132439
  3. Bacterial biofilms: a common cause of persistent infections.
    Science. 1999 May 21;284(5418):1318-22 PMID: 10334980
  4. A sandwich cup method for the penetration assay of antimicrobial agents through Pseudomonas exopolysaccharides.
    Microbiol Immunol. 1994;38(8):615-9 PMID: 7799834
  5. Pseudomonas aeruginosa biofilm as a diffusion barrier to piperacillin.
    Antimicrob Agents Chemother. 1992 Sep;36(9):2054-6 PMID: 1416900
  6. Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1998 Apr;42(4):974-7 PMID: 9559826
  7. Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms.
    Antimicrob Agents Chemother. 1994 Sep;38(9):2125-33 PMID: 7811031
  8. Genetic mapping of chromosomal determinants for the production of the exopolysaccharide alginate in a Pseudomonas aeruginosa cystic fibrosis isolate.
    Infect Immun. 1981 Jul;33(1):142-8 PMID: 6790439
  9. Biofilms, the customized microniche.
    J Bacteriol. 1994 Apr;176(8):2137-42 PMID: 8157581
  10. Microelectrode measurements of local mass transport rates in heterogeneous biofilms.
    Biotechnol Bioeng. 1998 Aug 5;59(3):302-9 PMID: 10099341
  11. Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic fibrosis-derived Pseudomonas aeruginosa.
    J Antimicrob Chemother. 1988 Nov;22(5):667-74 PMID: 3145268
  12. Riddle of biofilm resistance.
    Antimicrob Agents Chemother. 2001 Apr;45(4):999-1007 PMID: 11257008
  13. Effects of biofilm structures on oxygen distribution and mass transport.
    Biotechnol Bioeng. 1994 May;43(11):1131-8 PMID: 18615526
  14. Penetration of rifampin through Staphylococcus epidermidis biofilms.
    Antimicrob Agents Chemother. 2002 Mar;46(3):900-3 PMID: 11850284
  15. Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method.
    Chemotherapy. 1997 Sep-Oct;43(5):340-5 PMID: 9309367
  16. Mechanisms of antibiotic resistance in bacterial biofilms.
    Int J Med Microbiol. 2002 Jul;292(2):107-13 PMID: 12195733
  17. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials.
    J Bacteriol. 2001 Dec;183(23):6746-51 PMID: 11698361
  18. Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin.
    Antimicrob Agents Chemother. 1993 Sep;37(9):1749-55 PMID: 8239580
  19. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin.
    Antimicrob Agents Chemother. 2000 Jul;44(7):1818-24 PMID: 10858336
  20. Transmission electron microscopic study of antibiotic action on Klebsiella pneumoniae biofilm.
    Antimicrob Agents Chemother. 2002 Aug;46(8):2679-83 PMID: 12121956
  21. FACS-optimized mutants of the green fluorescent protein (GFP).
    Gene. 1996;173(1 Spec No):33-8 PMID: 8707053
  22. Antibiotic resistance of bacteria in biofilms.
    Lancet. 2001 Jul 14;358(9276):135-8 PMID: 11463434
  23. Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa bofilms displaying rapid-transport characteristics.
    Antimicrob Agents Chemother. 1997 Jun;41(6):1352-8 PMID: 9174198
  24. Amorphous ferrous sulfide as a reducing agent for culture of anaerobes.
    Appl Environ Microbiol. 1977 Feb;33(2):254-6 PMID: 192144
  25. Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans.
    Proc Natl Acad Sci U S A. 1979 Apr;76(4):1648-52 PMID: 377280
  26. Gene expression in Pseudomonas aeruginosa biofilms.
    Nature. 2001 Oct 25;413(6858):860-4 PMID: 11677611
  27. Resistance of bacterial biofilms to antibiotics: a growth-rate related effect?
    J Antimicrob Chemother. 1988 Dec;22(6):777-80 PMID: 3072331
  28. Theoretical aspects of antibiotic diffusion into microbial biofilms.
    Antimicrob Agents Chemother. 1996 Nov;40(11):2517-22 PMID: 8913456
  29. Spatial physiological heterogeneity in Pseudomonas aeruginosa biofilm is determined by oxygen availability.
    Appl Environ Microbiol. 1998 Oct;64(10):4035-9 PMID: 9758837
  30. Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms towards ciprofloxacin: effect of specific growth rate.
    J Antimicrob Chemother. 1991 Feb;27(2):177-84 PMID: 1905285
  31. Liquid flow in biofilm systems.
    Appl Environ Microbiol. 1994 Aug;60(8):2711-6 PMID: 16349345
  32. Identification of algI and algJ in the Pseudomonas aeruginosa alginate biosynthetic gene cluster which are required for alginate O acetylation.
    J Bacteriol. 1996 Apr;178(8):2186-95 PMID: 8636017
  33. Role of alginate and its O acetylation in formation of Pseudomonas aeruginosa microcolonies and biofilms.
    J Bacteriol. 2001 Feb;183(3):1047-57 PMID: 11208804
  34. Inhibition of tobramycin diffusion by binding to alginate.
    Antimicrob Agents Chemother. 1988 Apr;32(4):518-23 PMID: 3132093
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
2003-01-00
Pages
317-23
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC148957
Subset
IM
Grants
NIAID NIH HHS · R01 AI046588 · United States
NIAID NIH HHS · AI-46588 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com